Tocagen (NASDAQ: TOCA) reported Q4 EPS of ($0.55), $0.08 better than the analyst estimate of ($0.63). Licensing revenue for the quarter came in at $10 thousand versus the consensus estimate of $10 thousand.

For earnings history and earnings-related data on Tocagen (TOCA) click here.